Literature DB >> 25606714

Colloidal aggregation and the in vitro activity of traditional Chinese medicines.

Da Duan1,2, Allison K Doak1, Lyudmila Nedyalkova2, Brian K Shoichet1,2.   

Abstract

Traditional Chinese Medicines (TCMs) have been the sole source of therapeutics in China for two millennia. In recent drug discovery efforts, purified components of TCM formulations have shown activity in many in vitro assays, raising concerns of promiscuity. Here, we investigated 14 bioactive small molecules isolated from TCMs for colloidal aggregation. At concentrations commonly used in cell-based or biochemical assay conditions, eight of these compounds formed particles detectable by dynamic light scattering and showed detergent-reversible inhibition against β-lactamase and malate dehydrogenase, two counter-screening enzymes. When three of these compounds were tested against their literature-reported molecular targets, they showed similar reversal of their inhibitory activity in the presence of detergent. For three of the most potent aggregators, contributions to promiscuity via oxidative cycling were investigated; addition of 1 mM DTT had no effect on their activity, which is inconsistent with an oxidative mechanism. TCMs are often active at micromolar concentrations; this study suggests that care must be taken to control for artifactual activity when seeking their primary targets. Implications for the formulation of these molecules are considered.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25606714      PMCID: PMC4646422          DOI: 10.1021/cb5009487

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  74 in total

1.  A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening.

Authors:  Susan L McGovern; Emilia Caselli; Nikolaus Grigorieff; Brian K Shoichet
Journal:  J Med Chem       Date:  2002-04-11       Impact factor: 7.446

2.  A high-throughput screen for aggregation-based inhibition in a large compound library.

Authors:  Brian Y Feng; Anton Simeonov; Ajit Jadhav; Kerim Babaoglu; James Inglese; Brian K Shoichet; Christopher P Austin
Journal:  J Med Chem       Date:  2007-04-21       Impact factor: 7.446

3.  Semi-synthetic aristolactams--inhibitors of CDK2 enzyme.

Authors:  Vinod R Hegde; Scott Borges; Haiyan Pu; Mahesh Patel; Vincent P Gullo; Bonnie Wu; Paul Kirschmeier; Michael J Williams; Vincent Madison; Thierry Fischmann; Tze-Ming Chan
Journal:  Bioorg Med Chem Lett       Date:  2010-01-07       Impact factor: 2.823

4.  Brazilin inhibits activities of protein kinase C and insulin receptor serine kinase in rat liver.

Authors:  S G Kim; Y M Kim; L Y Khil; S D Jeon; D S So; C H Moon; C K Moon
Journal:  Arch Pharm Res       Date:  1998-04       Impact factor: 4.946

5.  Identification and initial SAR of silybin: an Hsp90 inhibitor.

Authors:  Huiping Zhao; Gary E Brandt; Lakshmi Galam; Robert L Matts; Brian S J Blagg
Journal:  Bioorg Med Chem Lett       Date:  2010-12-28       Impact factor: 2.823

6.  Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.

Authors:  Matthias B Wittwer; Arik A Zur; Natalia Khuri; Yasuto Kido; Alan Kosaka; Xuexiang Zhang; Kari M Morrissey; Andrej Sali; Yong Huang; Kathleen M Giacomini
Journal:  J Med Chem       Date:  2013-01-22       Impact factor: 7.446

7.  Synthesis and biological evaluation of phloridzin analogs as human concentrative nucleoside transporter 3 (hCNT3) inhibitors.

Authors:  Amol Gupte; John K Buolamwini
Journal:  Bioorg Med Chem Lett       Date:  2008-12-06       Impact factor: 2.823

8.  Structural aspects of flavonoids as trypsin inhibitors.

Authors:  Tibor Maliar; Andrej Jedinák; Jana Kadrabová; Ernest Sturdík
Journal:  Eur J Med Chem       Date:  2004-03       Impact factor: 6.514

9.  Interaction of digitalis-like compounds with p-glycoprotein.

Authors:  Elnaz Gozalpour; Hanneke G M Wittgen; Jeroen J M W van den Heuvel; Rick Greupink; Frans G M Russel; Jan B Koenderink
Journal:  Toxicol Sci       Date:  2012-10-26       Impact factor: 4.849

10.  Curcumin is a non-competitive and selective inhibitor of phosphorylase kinase.

Authors:  S Reddy; B B Aggarwal
Journal:  FEBS Lett       Date:  1994-03-14       Impact factor: 4.124

View more
  29 in total

1.  Identification of Compounds with Efficacy against Malaria Parasites from Common North American Plants.

Authors:  Shengxin Cai; April L Risinger; Shalini Nair; Jiangnan Peng; Timothy J C Anderson; Lin Du; Douglas R Powell; Susan L Mooberry; Robert H Cichewicz
Journal:  J Nat Prod       Date:  2015-12-21       Impact factor: 4.050

2.  An Aggregation Advisor for Ligand Discovery.

Authors:  John J Irwin; Da Duan; Hayarpi Torosyan; Allison K Doak; Kristin T Ziebart; Teague Sterling; Gurgen Tumanian; Brian K Shoichet
Journal:  J Med Chem       Date:  2015-08-28       Impact factor: 7.446

3.  Internal Structure and Preferential Protein Binding of Colloidal Aggregates.

Authors:  Da Duan; Hayarpi Torosyan; Daniel Elnatan; Christopher K McLaughlin; Jennifer Logie; Molly S Shoichet; David A Agard; Brian K Shoichet
Journal:  ACS Chem Biol       Date:  2016-12-16       Impact factor: 5.100

Review 4.  Counting on natural products for drug design.

Authors:  Tiago Rodrigues; Daniel Reker; Petra Schneider; Gisbert Schneider
Journal:  Nat Chem       Date:  2016-04-25       Impact factor: 24.427

5.  Colloidal Drug Aggregate Stability in High Serum Conditions and Pharmacokinetic Consequence.

Authors:  Ahil N Ganesh; Ahmed Aman; Jennifer Logie; Ben L Barthel; Peter Cogan; Rima Al-Awar; Tad H Koch; Brian K Shoichet; Molly S Shoichet
Journal:  ACS Chem Biol       Date:  2019-03-12       Impact factor: 5.100

6.  Activation of Human Transient Receptor Potential Melastatin-8 (TRPM8) by Calcium-Rich Particulate Materials and Effects on Human Lung Cells.

Authors:  John G Lamb; Erin G Romero; Zhenyu Lu; Seychelle K Marcus; Hannah C Peterson; John M Veranth; Cassandra E Deering-Rice; Christopher A Reilly
Journal:  Mol Pharmacol       Date:  2017-10-16       Impact factor: 4.436

7.  Mechanisms of Specific versus Nonspecific Interactions of Aggregation-Prone Inhibitors and Attenuators.

Authors:  Stephen Boulton; Rajeevan Selvaratnam; Rashik Ahmed; Katherine Van; Xiaodong Cheng; Giuseppe Melacini
Journal:  J Med Chem       Date:  2019-05-10       Impact factor: 7.446

8.  Colloidal aggregation: from screening nuisance to formulation nuance.

Authors:  Ahil N Ganesh; Eric N Donders; Brian K Shoichet; Molly S Shoichet
Journal:  Nano Today       Date:  2018-03-10       Impact factor: 20.722

9.  Protein Stability Effects in Aggregate-Based Enzyme Inhibition.

Authors:  Hayarpi Torosyan; Brian K Shoichet
Journal:  J Med Chem       Date:  2019-10-17       Impact factor: 7.446

10.  Antibacterial Flavonoids from Medicinal Plants Covalently Inactivate Type III Protein Secretion Substrates.

Authors:  Lun K Tsou; María Lara-Tejero; Jordan RoseFigura; Zhenrun J Zhang; Yen-Chih Wang; Jacob S Yount; Matthew Lefebre; Paul D Dossa; Junya Kato; Fulan Guan; Wing Lam; Yung-Chi Cheng; Jorge E Galán; Howard C Hang
Journal:  J Am Chem Soc       Date:  2016-02-16       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.